JFS Wealth Advisors’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.89K Buy
55
+15
+38% +$810 ﹤0.01% 1384
2026
Q1
$2.09K Sell
40
-11
-22% -$660 ﹤0.01% 1494
2025
Q4
$3K Buy
51
+49
+2,450% +$2.98K ﹤0.01% 1424
2025
Q3
$112 Hold
2
﹤0.01% 1843
2025
Q2
$103 Sell
2
-22
-92% -$1.1K ﹤0.01% 1810
2025
Q1
$1.41K Sell
24
-42
-64% -$2.85K ﹤0.01% 1579
2024
Q4
$4.75K Sell
66
-5
-7% -$367 ﹤0.01% 1146
2024
Q3
$5.68K Buy
71
+14
+25% +$1.05K ﹤0.01% 1078
2024
Q2
$4.08K Buy
57
+5
+10% +$368 ﹤0.01% 1148
2024
Q1
$3.66K Buy
52
+20
+63% +$1.43K ﹤0.01% 1218
2023
Q4
$2.47K Sell
32
-32
-50% -$2.11K ﹤0.01% 1336
2023
Q3
$4.36K Buy
64
+9
+16% +$711 ﹤0.01% 1048
2023
Q2
$4.49K Buy
55
+25
+83% +$2.01K ﹤0.01% 1051
2023
Q1
$2.23K Sell
30
-24
-44% -$1.85K ﹤0.01% 1319
2022
Q4
$4.48K Buy
54
+2
+4% +$159 ﹤0.01% 1032
2022
Q3
$4K Buy
52
+24
+86% +$2.07K ﹤0.01% 1107
2022
Q2
$2K Hold
28
﹤0.01% 1391
2022
Q1
$3K Buy
28
+4
+17% +$413 ﹤0.01% 1323
2021
Q4
$3K Buy
+24
New +$2.94K ﹤0.01% 993

Other funds holding TECH

JFS Wealth Advisors's TECH Position: Q2 2026 in Review

JFS Wealth Advisors increased its Bio-Techne (TECH) stake by 38% in Q2 2026, buying an estimated $810 and bringing the position to 55 shares worth $3.89K. The position accounts for ﹤0.01% of the portfolio, ranked #1384.

JFS Wealth Advisors first reported a position in TECH in Q4 2021 and has held it in 19 quarters since. The position peaked at $5.68K in Q3 2024. 595 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • JFS Wealth Advisors held 55 shares of Bio-Techne worth $3.89K as of Q2 2026.
  • JFS Wealth Advisors bought 15 Bio-Techne shares in Q2 2026, an estimated $810.
  • Bio-Techne made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #1384 holding.
  • JFS Wealth Advisors first reported a position in Bio-Techne in Q4 2021 and has held it in 19 quarters since.
  • JFS Wealth Advisors's Bio-Techne position peaked at $5.68K in Q3 2024.
  • 595 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.